Update on Immunotherapeutics in the Management of Metastatic Melanoma

Q1 Medicine Skin therapy letter Pub Date : 2019-01-01
David Bulir, Steven Liang, Maureen O’Malley, Elaine McWhirter
{"title":"Update on Immunotherapeutics in the Management of Metastatic Melanoma","authors":"David Bulir,&nbsp;Steven Liang,&nbsp;Maureen O’Malley,&nbsp;Elaine McWhirter","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Today, a number of treatment options are now available for metastatic melanoma. Within the last decade, the development of novel immunotherapies for cancer has significantly altered the course of the disease in patients with melanoma. With more patients receiving these potentially life-saving treatments, not only have we learned more about the interplay between the immune system and melanoma, but more importantly, which treatment options are most appropriate given the clinical picture.</p>","PeriodicalId":21829,"journal":{"name":"Skin therapy letter","volume":"24 1","pages":"8-11"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin therapy letter","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Today, a number of treatment options are now available for metastatic melanoma. Within the last decade, the development of novel immunotherapies for cancer has significantly altered the course of the disease in patients with melanoma. With more patients receiving these potentially life-saving treatments, not only have we learned more about the interplay between the immune system and melanoma, but more importantly, which treatment options are most appropriate given the clinical picture.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
转移性黑色素瘤的免疫治疗进展
如今,对于转移性黑色素瘤有许多治疗选择。在过去的十年里,新型癌症免疫疗法的发展显著地改变了黑色素瘤患者的病程。随着越来越多的患者接受这些可能挽救生命的治疗,我们不仅更多地了解了免疫系统和黑色素瘤之间的相互作用,更重要的是,根据临床情况,哪种治疗方案是最合适的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Skin therapy letter
Skin therapy letter Medicine-Medicine (all)
CiteScore
2.80
自引率
0.00%
发文量
0
期刊介绍: The premier international journal on the latest advances, techniques and practice in conservation and restoration from around the world.
期刊最新文献
An Update on the Clinical Management of Cutaneous Leishmaniasis. Pediatric Hidradenitis Suppurativa: An Overview. A Multimodal Approach to Acne-Induced Post-Inflammatory Hyperpigmentation: Trifarotene as a Long-Term Intervention. A Review of the Role and Treatment of Biofilms in Skin Disorders. Enhancing Bioavailability: Advances in Oral Isotretinoin Formulations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1